AAPS Election

Call for Board of Directors Nominations


The AAPS Nominations Committee is seeking nominations for AAPS president-elect and members-at-large for terms beginning at the 2019 AAPS PharmSci 360. Candidates for the AAPS Board of Directors must be AAPS members.

AAPS depends on elected Board of Directors members to fulfill our mission to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health. Service on the Board is a chance to grow personally and professionally, to develop skills, gain unique experience, and make lasting connections with a team of other passionate and motivated professionals.

Help lead AAPS and your profession into the future. We invite you to apply to be part of this dynamic and exciting team. Refer to the AAPS Board of Directors Election Handbook (PDF) for more information.

Nominate yourself or a colleague by emailing a completed Call for Nominations Form (DOCX) by January, 18, 2019 to Maria Nadeau at NadeauM@aaps.org.

For more information, email Maria Nadeau at NadeauM@aaps.org or call +1.703.248.4709. 

2018 AAPS Election Results

AAPS is pleased to announce that the AAPS membership has elected the following individuals to the AAPS Board of Directors. Their terms of office begin during PharmSci 360, November 4–7, in Washington, DC.

The Board of Directors thanks all the members who participated in this year’s election. Your dedication and support of AAPS helps make the organization vibrant and effective in the pursuit of AAPS' mission: To advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.


thumbnail image
Joseph W. Polli, Ph.D., FAAPS


thumbnail image
Mark J. Rose, Ph.D.
CHDI Management, Inc.

thumbnail image
Douglas H. Sweet, Ph.D.
Virginia Commonwealth University 

Polli, Rose, and Sweet will join the following members on the 2019 Board of Directors: Members-at-Large Reina Bendayan, Pharm.D., FAAPS, University of Toronto; Allen C. Templeton, Ph.D., FAAPS, Merck & Co., Inc; Annette Bak, Ph.D., M.B.A., AstraZeneca; Bernd W. Meibohm, Ph.D., F.C.P., FAAPS, the University of Tennessee Health Science Center; and President Dale E. Wurster, Ph.D., and Past President Christopher R. McCurdy, Ph.D., R.Ph., FAAPS.